한국어
English
日本語
中文(简体)
Letevmo Capsule 80 mg (Selpercatinib)
80mg
Hard capsule · Prescription medication
Eli Lilly Korea, Inc.
Selpercatinib is a targeted anticancer agent used for the treatment of cancers with RET gene mutations.
MFDS ingredient code M282097
Selpercatinib belongs to the class of anticancer drugs known as RET kinase inhibitors, and it is used to inhibit the growth of cancer cells with RET gene mutations. It is primarily utilized in the treatment of lung cancer and thyroid cancer with specific gene mutations.
Selpercatinib blocks the abnormal activation of the RET protein, preventing the signaling that allows cancer cells to proliferate. As a result, the growth of cancer cells is inhibited and apoptosis is promoted.
Approved uses differ by product. Check each product's information for its actual use.
Selpercatinib is a targeted therapy that specifically acts on RET gene mutations, causing less damage to normal cells compared to traditional chemotherapy agents, and it tends to have relatively fewer side effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
